drugset / Trial / NCT00863980
Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
RandomizedParallel-groupSingle-blindPrevention
Summary
This study is aimed to investigate whether treatment with Telmisartan is more effective than Candesartan in reducing the ischemic cardiovascular events in high-risk patients with cardiovascular disease.
Timeline
- Start
- 2009-04
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Candesartan | Unknown | 8 mg | Oral |
| Comparator | Candesartan | Unknown | 12 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 40 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 80 mg | Oral |